Tumor Necrosis Factor-alpha Gene Transfer Augments Anti-Fas Antibody-mediated Apoptosis in Human Glioma Cells
Overview
Affiliations
To effectively induce apoptosis in human glioma cells, we tried to transfer the tumor necrosis factor (TNF)-alpha gene into glioma cells to produce TNF-alpha locally in these cells. The stable transfectants of three glioma cells (U251-SP, U251-MG, and T98G) were resistant to exogenous TNF-alpha, but their cell surface expression of the Fas antigen was dramatically enhanced by about 10 to 100-fold as compared with untransfected glioma cells exposed to exogenous TNF-alpha. The Fas antigen is a transmembrane cytokine receptor protein of the nerve growth factor/TNF receptor superfamily. Although the untransfected glioma cells tested were resistant to anti-Fas antibody-mediated apoptosis, the TNF-alpha gene-transfected glioma cells exhibited high susceptibility to anti-Fas antibody-mediated apoptosis. Thus, TNF-alpha gene transfer combined with anti-Fas antibodies may be useful for the treatment of malignant glioma.
Role of astrocytes in pathogenesis of ischemic brain injury.
Gabryel B, Trzeciak H Neurotox Res. 2004; 3(2):205-21.
PMID: 14715474 DOI: 10.1007/BF03033192.
Induction of apoptosis in glioma cells by molecules released from activated macrophages.
Chen G, Chu Y, Chak E, Leung B, Poon W J Neurooncol. 2002; 57(3):179-86.
PMID: 12125980 DOI: 10.1023/a:1015763916020.
Martin-Villalba A, Herr I, Jeremias I, Hahne M, Brandt R, Vogel J J Neurosci. 1999; 19(10):3809-17.
PMID: 10234013 PMC: 6782733.
CD95 ligand: lethal weapon against malignant glioma?.
Weller M, Kleihues P, Dichgans J, Ohgaki H Brain Pathol. 1998; 8(2):285-93.
PMID: 9546287 PMC: 8098168. DOI: 10.1111/j.1750-3639.1998.tb00154.x.